25 May 2013
Keywords: Japan, Bioventures, IPOs, Financing, Investment
Article | 13 October 2009
It is difficult to be optimistic about the future of Japanese bioventures. To date the track record is miserable. Out ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.